全文获取类型
收费全文 | 285806篇 |
免费 | 25721篇 |
国内免费 | 12372篇 |
专业分类
耳鼻咽喉 | 2336篇 |
儿科学 | 3342篇 |
妇产科学 | 3416篇 |
基础医学 | 56360篇 |
口腔科学 | 6206篇 |
临床医学 | 20378篇 |
内科学 | 46606篇 |
皮肤病学 | 4500篇 |
神经病学 | 21866篇 |
特种医学 | 5992篇 |
外国民族医学 | 73篇 |
外科学 | 20896篇 |
综合类 | 39997篇 |
现状与发展 | 40篇 |
一般理论 | 8篇 |
预防医学 | 11617篇 |
眼科学 | 4538篇 |
药学 | 39817篇 |
56篇 | |
中国医学 | 10767篇 |
肿瘤学 | 25088篇 |
出版年
2024年 | 483篇 |
2023年 | 4430篇 |
2022年 | 7958篇 |
2021年 | 12656篇 |
2020年 | 10123篇 |
2019年 | 8708篇 |
2018年 | 8606篇 |
2017年 | 9057篇 |
2016年 | 9660篇 |
2015年 | 11141篇 |
2014年 | 17195篇 |
2013年 | 20043篇 |
2012年 | 16868篇 |
2011年 | 19552篇 |
2010年 | 16131篇 |
2009年 | 16085篇 |
2008年 | 16052篇 |
2007年 | 15145篇 |
2006年 | 13659篇 |
2005年 | 11865篇 |
2004年 | 9912篇 |
2003年 | 8580篇 |
2002年 | 6710篇 |
2001年 | 5560篇 |
2000年 | 4728篇 |
1999年 | 4192篇 |
1998年 | 3926篇 |
1997年 | 3645篇 |
1996年 | 3272篇 |
1995年 | 3094篇 |
1994年 | 2780篇 |
1993年 | 2423篇 |
1992年 | 2017篇 |
1991年 | 1914篇 |
1990年 | 1598篇 |
1989年 | 1437篇 |
1988年 | 1310篇 |
1987年 | 1145篇 |
1986年 | 1023篇 |
1985年 | 1568篇 |
1984年 | 1456篇 |
1983年 | 1032篇 |
1982年 | 1141篇 |
1981年 | 894篇 |
1980年 | 759篇 |
1979年 | 644篇 |
1978年 | 430篇 |
1977年 | 348篇 |
1976年 | 326篇 |
1975年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
23.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
24.
25.
《Digestive and liver disease》2022,54(11):1486-1493
BackgroundCold snare polypectomy (CSP) is a promising technique for the removal of sessile serrated polyps (SSPs) ≥ 10 mm. However, the efficacy and safety of this technique remain undetermined.AimsWe aimed to comprehensively evaluate the efficacy and safety of CSP for SSPs ≥ 10 mm.MethodsPubMed, EMBASE, Web of Science and Cochrane Library were searched up to January 2021.ResultsA total of 10 studies consisting of 1727 SSPs (range, 10–40 mm) from 1021 patients were included. The overall rates of technical success, adverse events (AEs) and residual SSPs were 100%, 0.7% and 2.9%, respectively. Subgroup analysis showed that the rates of technical success and AEs were comparable between CSP and cold endoscopic mucosal resection (EMR) (99.9% vs. 100% and 1.3% vs. 0.5%, respectively), between the proximal and distal colon (100% vs. 99.9% and 0.3% vs. 0, respectively), and between polyps of 10–19 mm and ≥20 mm (99.8% vs. 100% and 0.9% vs. 0, respectively). However, subgroup analysis showed that the rate of residual SSPs was slightly lower in CSP compared with cold EMR (1.3% vs. 3.9%), as well as in polyps of 10–19 mm compared with those ≥20 mm (3.1% vs. 4.7%).ConclusionCSP was an effective and safe technique for removing SSPs ≥ 10 mm. 相似文献
26.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
27.
《Vaccine》2022,40(32):4296-4300
Advanced computational methodologies suggested SARS-CoV-2, nonstructural proteins ORF1AB, ORF3a, as the source of immunodominant peptides for T cell presentation. T cell immunity is long-lasting and compatible with COVID-19 pathology. Based on the supporting clinical data, nonstructural SARS-CoV-2 protein vaccines could provide global immunity against COVID-19. 相似文献
28.
29.
《Transfusion and apheresis science》2022,61(4):103488
The COVID-19 pandemic caused by the SARS-CoV-2 virus has significantly disrupted and burdened the diagnostic workup and delivery of care, including transfusion, to cancer patients across the globe. Furthermore, cancer patients suffering from solid tumors or hematologic malignancies were more prone to the infection and had higher morbidity and mortality than the rest of the population. Major signaling pathways have been identified at the intersection of SARS-CoV-2 and cancer cells, often leading to tumor progression or alteration of the tumor response to therapy. The reactivation of oncogenic viruses has also been alluded to in the context and following COVID-19. Paradoxically, certain tumors responded better following the profound infection-induced immune modulation. Unveiling the mechanisms of the virus-tumor cell interactions will lead to a better understanding of the pathophysiology of both cancer progression and virus propagation. It would be challenging to monitor, through the different cancer registries, retrospectively, the response of patients who have been previously exposed to the virus in contrast to those who have not contracted the infection. 相似文献
30.